BioMarin Pharmaceutical Inc. Stock News

Sanofi SA (SNY) has made it clear it wants to get into the rapidly growing gene therapy market, and an acquisition may be the fastest route.

As of late, it has definitely been a great time to be an investor in BioMarin Pharmaceutical.

As of late, it has definitely been a great time to be an investor in BioMarin Pharmaceutical.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide Research & Development and Brian Mueller, Acting Chief Financial Officer, will participate in t

In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on VBI Vaccines (VBIV – Research Report),

Two Sigma Advisers LP trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 84.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exch

In a tug of war between bulls and bears, the Dow Jones and S&P; 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.

In a tug of war between bulls and bears, the Dow Jones and S&P 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.

Stocks Analysis by Zacks Investment Research covering: Vertex Pharmaceuticals Inc, Gilead Sciences Inc, Apple Inc, Rambus Inc. Read Zacks Investment Research's latest article on Investing.com

Mackenzie Financial Corp purchased a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) during the first quarter, Holdings Channel reports. The firm purchased 3,946 shares of the bio

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) – Analysts at Oppenheimer dropped their Q3 2020 earnings per share estimates for shares of BioMarin Pharmaceutical in a research note issued to investors o

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s share price gapped up before the market opened on Thursday after SunTrust Banks raised their price target on the stock from $109.00 to $143.00. The stock

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) ADC Therapeutics SA (NYSE:...